Coldstream Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Buy
1,764
+258
+17% +$43K ﹤0.01% 1015
2026
Q1
$316K Sell
1,506
-198
-12% -$49.8K ﹤0.01% 910
2025
Q4
$484K Sell
1,704
-261
-13% -$81.6K 0.01% 740
2025
Q3
$607K Buy
1,965
+221
+13% +$69.2K 0.01% 649
2025
Q2
$548K Sell
1,744
-565
-24% -$163K 0.01% 618
2025
Q1
$606K Sell
2,309
-395
-15% -$107K 0.01% 524
2024
Q4
$706K Sell
2,704
-189
-7% -$47.6K 0.02% 474
2024
Q3
$714K Buy
2,893
+1,710
+145% +$351K 0.02% 483
2024
Q2
$239K Buy
+1,183
New +$213K 0.01% 858
2024
Q1
– Sell
-1,594
Closed -$346K – 1025
2023
Q4
$346K Buy
+1,594
New +$273K 0.01% 652

Other funds holding PODD

Coldstream Capital Management's PODD Position: Q2 2026 in Review

Coldstream Capital Management increased its Insulet (PODD) stake by 17% in Q2 2026, buying an estimated $43K and bringing the position to 1,764 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #1015.

Coldstream Capital Management first reported a position in PODD in Q4 2023 and has held it in 10 quarters since. The position peaked at $714K in Q3 2024. 731 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Coldstream Capital Management held 1,764 shares of Insulet worth $269K as of Q2 2026.
  • Coldstream Capital Management bought 258 Insulet shares in Q2 2026, an estimated $43K.
  • Insulet made up ﹤0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #1015 holding.
  • Coldstream Capital Management first reported a position in Insulet in Q4 2023 and has held it in 10 quarters since.
  • Coldstream Capital Management's Insulet position peaked at $714K in Q3 2024.
  • 731 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.